Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.
Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain. This triggers a reaction that damages blood vessels and causes neurodegeneration.
Receiving a clot-busting drug in an ambulance-based mobile stroke unit increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, a new study shows.
Research findings suggest that women who took hormones in midlife to treat their menopause symptoms were less likely to develop dementia than those who hadn’t taken estrogen.
Mental health crises among children and adolescents requiring emergency department care skyrocketed during the pandemic and have stayed elevated despite a return to normalcy, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Cornell Tech has announced a total of more than $10 million in gifts and grants from the Simons Foundation and the National Science Foundation, respectively, to support arXiv, a free distribution service and open-access archive for scholarly articles.
In experiments of unprecedented scale, researchers at Weill Cornell Medicine and the NIH have advanced efforts to better understand and ultimately treat this common metabolic disease.
Weill Cornell Medicine is constructing a modern student residence that, when it opens in 2025, will nearly double the existing student residential living space.
Entrepreneurs will gather to hear fireside chats with top business leaders, enjoy multiple networking and engagement opportunities and hear startup pitches at Entrepreneurship at Cornell’s Eclectic Convergence 2023.
